Albert Einstein College of Medicine, the Bronx, New York.
Allergy Division Chair, Mayo Clinic, Rochester, Minnesota.
Otol Neurotol. 2023 Dec 1;44(10):1100-1105. doi: 10.1097/MAO.0000000000004027. Epub 2023 Sep 29.
To evaluate long-term effects of COVID-19 on auditory and vestibular symptoms in a diverse cohort impacted by the initial 2020 COVID-19 infection in the pandemic's epicenter, before vaccine availability.
Cohort study of individuals with confirmed COVID-19 infection, diagnosed in the March-May 2020 infection wave. A randomized, retrospective chart review of 1,352 individuals was performed to identify those with documented new or worsening auditory (aural fullness, tinnitus, hyperacusis, hearing loss) or vestibular (dizziness, vertigo) symptoms. Those with documented symptoms (613 of the 1,352 initial cohort) were contacted for a follow-up telephone survey in 2021-2022 to obtain self-report of aforementioned symptoms.
Academic tertiary hospital system in Bronx, NY.
Adults 18 to 99 years old with confirmed COVID-19 infection, alive at time of review. One hundred forty-eight charts were excluded for restricted access, incomplete data, no COVID-19 swab, or deceased at time of review.
Confirmed COVID-19 infection, March to May 2020.
Auditory and vestibular symptoms documented in 2020 medical records and by self-report on 2021 to 2022 survey.
Among the 74 individuals with documented symptoms during the first 2020 COVID-19 wave who participated in the 2021 to 2022 follow-up survey, 58% had documented vestibular symptoms initially in 2020, whereas 43% reported vestibular symptoms on the 2021 to 2022 survey ( p = 0.10). In contrast, 9% had documented auditory symptoms initially in 2020 and 55% reported auditory symptoms on the 2021 to 2022 survey ( p < 0.01).
COVID-19 may impact vestibular symptoms early and persistently, whereas auditory effects may have more pronounced long-term impact, suggesting the importance of continually assessing COVID-19 patients.
在疫苗可及之前,评估最初 2020 年 COVID-19 感染大流行期间在疫情中心受影响的多样化队列中 COVID-19 对听觉和前庭症状的长期影响。
这是一项队列研究,纳入了在 2020 年 3 月至 5 月感染波中确诊的 COVID-19 感染患者。对 1352 名患者进行了随机、回顾性图表审查,以确定有记录的新发或加重的听觉(耳闷、耳鸣、听觉过敏、听力损失)或前庭(头晕、眩晕)症状的患者。对有记录症状的 613 名最初队列患者在 2021 年至 2022 年进行了后续电话调查,以获取上述症状的自我报告。
纽约布朗克斯的学术三级医院系统。
18 至 99 岁,确诊 COVID-19 感染,在复查时存活。有 148 份图表因受限访问、数据不完整、无 COVID-19 拭子或复查时死亡而被排除。
确诊 COVID-19 感染,时间为 2020 年 3 月至 5 月。
2020 年医疗记录中记录的听觉和前庭症状以及 2021 年至 2022 年调查中的自我报告。
在最初的 2020 年 COVID-19 波期间有记录症状且参加了 2021 年至 2022 年随访调查的 74 名患者中,58%的患者在 2020 年最初有记录的前庭症状,而 43%的患者在 2021 年至 2022 年调查中有前庭症状(p=0.10)。相比之下,9%的患者最初在 2020 年有记录的听觉症状,而 55%的患者在 2021 年至 2022 年调查中有听觉症状(p<0.01)。
COVID-19 可能会早期持续地影响前庭症状,而听觉影响可能具有更明显的长期影响,这表明持续评估 COVID-19 患者的重要性。